Thoratec Presentation At Credit Suisse 2012 Healthcare Conference To Be Webcast

Mon Nov 12, 2012 5:00pm EST

* Reuters is not responsible for the content in this press release.

Thoratec Presentation At Credit Suisse 2012 Healthcare Conference To Be Webcast

PR Newswire

PLEASANTON, Calif., Nov. 12, 2012 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Credit Suisse 2012 Healthcare Conference on Thursday, November 15.

Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company beginning at 9 a.m., Mountain Standard Time (11 a.m., Eastern Standard Time). The presentation will be available through the conference website at http://cc.talkpoint.com/cred001/111412a_am/?entity=6_1P7H34G or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

SOURCE Thoratec Corporation

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.